ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
Dow Jones
39.118,86
-0,12%
Euro vs US Dollar
1,07205
0,00%
Bitcoin
60.860,84
0,91%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) News

NHWK

Nighthawk Biosciences (NHWK)

Nighthawk Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:NHWK
DatumZeitQuelleÜberschriftSymbolFirma
03/05/202422h00Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:NHWKNighthawk Biosciences Inc
03/05/202413h18Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:NHWKNighthawk Biosciences Inc
02/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
30/04/202414h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
29/04/202414h10Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
22/04/202423h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
01/04/202422h52Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NHWKNighthawk Biosciences Inc
19/03/202413h30GlobeNewswire Inc.Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major UniversityAMEX:NHWKNighthawk Biosciences Inc
14/03/202413h30GlobeNewswire Inc.Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-ConsortiumAMEX:NHWKNighthawk Biosciences Inc
13/03/202411h17Edgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]AMEX:NHWKNighthawk Biosciences Inc
13/03/202411h01Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
12/03/202422h00GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Closing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
08/03/202406h20GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Pricing of Public OfferingAMEX:NHWKNighthawk Biosciences Inc
07/03/202422h18GlobeNewswire Inc.Scorpius Holdings, Inc. Announces Proposed Public Offering of Common StockAMEX:NHWKNighthawk Biosciences Inc
07/03/202414h30GlobeNewswire Inc.Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023AMEX:NHWKNighthawk Biosciences Inc
06/02/202415h34Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
06/02/202414h00GlobeNewswire Inc.NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open TodayAMEX:NHWKNighthawk Biosciences Inc
01/02/202414h00GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating OfficerAMEX:NHWKNighthawk Biosciences Inc
30/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
30/01/202414h00GlobeNewswire Inc.NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing NoteAMEX:NHWKNighthawk Biosciences Inc
26/01/202422h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
25/01/202414h30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical ProgramAMEX:NHWKNighthawk Biosciences Inc
22/01/202414h00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
16/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
16/01/202414h30GlobeNewswire Inc.NightHawk’s Scorpius BioManufacturing Subsidiary Commences Work on Preclinical Program for New ClientAMEX:NHWKNighthawk Biosciences Inc
11/01/202422h59Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
08/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
08/01/202414h30GlobeNewswire Inc.NightHawk Biosciences Announces Planned Name Change to Scorpius Holdings, Reflecting Successful Transition to a Large Molecule Biomanufacturing CDMOAMEX:NHWKNighthawk Biosciences Inc
03/01/202414h30GlobeNewswire Inc.NightHawk Biosciences Commences Work on Multi-Million-Dollar Development and Manufacturing Agreement For a Leading National UniversityAMEX:NHWKNighthawk Biosciences Inc
27/12/202322h57Edgar (US Regulatory)Form 8-K - Current reportAMEX:NHWKNighthawk Biosciences Inc
 Showing the most relevant articles for your search:AMEX:NHWK

Kürzlich von Ihnen besucht

LSE
0NEY
Usu Software
EU
INDAC
Infra Park 1.625% 19apr2...
LVCN
XVGETH
Verge
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten